← FDA Drug Approvals (Drugs@FDA)

RECARBRIO

NDA · New Drug Application · Sponsor: MSD MERCK CO · Approved 2019-07-16

Drug application

FDA Application #

NDA212819

Application type

New Drug Application

Brand name

RECARBRIO

Generic name

IMIPENEM ANHYDROUS, CILASTATIN, AND RELEBACTAM ANHYDROUS

Active ingredients

CILASTATIN SODIUM; IMIPENEM; RELEBACTAM

Dosage form

POWDER

Route

INTRAVENOUS

Marketing status

Prescription

Sponsor

MSD MERCK CO

Manufacturer

Merck Sharp & Dohme LLC

First approval

2019-07-16

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown